Gait analysis of spinal cord injured	1
Gait	1
analysis of spinal cord	6
analysis	6
spinal cord	18
rats	38
delivery	49
chondroitinase	61
ABC and adult olfactory mucosa progenitor	76
ABC	76
adult olfactory mucosa progenitor	84
cell transplantation	118
Wen-Cheng Huanga , b , d	139
Wen-Cheng Huanga	139
b	156
d	158
Wen-Chun	163
Kuoa	172
Sung-Hao Hsua	178
f	192
Chu-Hsun Chenga	195
d	211
Jiang-Chuan Liuc	214
Henrich Chenga	232
b	247
d	249
a Center	255
Neural Regeneration	268
Department of Neurosurgery	289
Department	289
Neurosurgery	303
Neurological Institute	317
Taipei Veterans General Hospital	341
Taipei	375
Taiwan	383
ROC b Graduate Institute of Medical Sciences	391
ROC b Graduate Institute	391
Medical Sciences	419
National Defense Medical Center	437
Taipei , Taiwan , ROC c Institute of Biology and Anatomy	470
Taipei , Taiwan , ROC c Institute	470
Biology and Anatomy	505
National Defense Medical Center	526
Taipei , Taiwan , ROC d Department and Institute of Pharmacology	559
Taipei , Taiwan , ROC d Department	559
Institute of Pharmacology	596
Institute	596
Pharmacology	609
School	623
Medicine , National Yang-Ming University , Taipei , Taiwan , ROC	633
Faculty of Medicine	696
Faculty	696
Medicine	707
School of Medicine	717
School	717
Medicine	727
National Yang-Ming University	737
Taipei	768
Taiwan	776
ROC f Institute of Zoology	784
ROC	784
f Institute of Zoology	788
Institute	790
Zoology	803
College of Life Science	812
College	812
Life Science	823
National Taiwan University	837
Taiwan	865
ROC Abstract Chondroitin	873
sulfate proteoglycan -LRB- CSPG -RRB-	899
sulfate proteoglycan	899
CSPG	921
a major component	930
glial scar	951
axonal regeneration in the lesion site	974
axonal regeneration	974
the lesion site	997
spinal cord injury	1019
SCI	1039
Chondroitinase ABC -LRB- ChABC -RRB-	1045
Chondroitinase ABC	1045
ChABC	1065
a bacteria enzyme	1073
the glycosaminoglycan	1130
GAG	1153
side chain of CSPG to promote axonal regrowth across the injured site	1158
side chain	1158
CSPG	1172
axonal regrowth	1188
the injured site	1211
Our previous study	1229
long-term delivery	1263
ChABC -LRB- 1 U/ml , injection volume 0.6 µl for one animal -RRB-	1285
ChABC	1285
1 U/ml , injection volume 0.6 µl for one animal	1292
1 U/ml	1292
injection volume 0.6 µl for one animal	1300
injection volume	1300
0.6 µl for one animal	1317
0.6 µl	1317
one animal	1327
intrathecal catheter	1343
the inhibitory effect of limiting axonal re-growth after SCI	1379
the inhibitory effect	1379
axonal re-growth	1413
SCI	1436
The functional behavior	1441
following ChABC treatment	1491
Little axons re-grow	1518
the lesion site of the spinal cord but not enough	1546
the lesion site	1546
the spinal cord but not enough	1565
the spinal cord	1565
enough	1589
axon innervations	1607
targets	1628
this article	1640
we	1654
ChABC administration	1667
olfactory mucosa progenitor cell -LRB- OMPC -RRB-	1698
olfactory mucosa progenitor cell	1698
OMPC	1732
transplantation	1738
axonal re-growth	1766
the lesion site	1790
the consistency of stepping in spinally transected rats	1818
the consistency	1818
spinally transected rats	1849
These OMPCs	1875
NG2 + cell lineages after transplanting into the spinal cord parenchyma	1897
NG2 + cell lineages	1897
the spinal cord parenchyma	1941
OMPCs	1973
the lesion region of spinal cord	2019
the lesion region	2019
spinal cord	2040
the spatial and temporal characteristics of the step cycle in rats that	2063
the spatial and temporal characteristics	2063
the step cycle in rats that	2107
the step cycle	2107
rats that	2125
rats	2125
a complete spinal cord transaction	2143
continuousChABCsupply andOMPCtransplantation	2188
The gait characteristics of treated rats on a treadmill	2234
The gait characteristics	2234
treated rats on a treadmill	2262
treated rats	2262
a treadmill	2278
that of intact rats	2321
that	2321
intact rats	2329
future	2345
the mechanism of restoring the injured spinal cord	2353
the mechanism	2353
the injured spinal cord	2380
Fig. 1 .	2436
Fig.	2436
1	2441
-LRB- A -RRB-	2444
Morphology and cellular proliferation rates	2448
olfactory mucosa-derived progenitor cells , which were pre-induced by GDNF	2495
olfactory mucosa-derived progenitor cells	2495
GDNF	2564
-LRB- B -RRB- These OMPCs	2570
-LRB- B -RRB-	2570
These OMPCs	2574
a greater number	2596
neuritis	2626
red arrow	2636
GDNF-containing medium in culture	2673
GDNF-containing medium	2673
culture	2699
they	2712
the negative control method	2729
The OMPCs	2758
GDNF-induction for 7 days	2791
GDNF-induction	2791
7 days	2810
immunocytochemistry assay	2818
cellular determination	2857
various antibodies such as NG2 and O4	2885
various antibodies	2885
NG2 and O4	2912
7 days , -LRB- C -RRB-	2930
7 days	2930
C	2939
a large number of GDNF-induced OMPCs	2942
a large number	2942
GDNF-induced OMPCs	2960
NG2 -LRB- a marker of oligodendrocyte progenitor cells -RRB- and O4	2989
NG2	2989
a marker of oligodendrocyte progenitor cells	2994
a marker	2994
oligodendrocyte progenitor cells	3006
O4	3044
few NG2 + cells	3057
few NG2	3057
cells	3066
O4	3090
similar to GDNF-induced OMPCs , -LRB- D -RRB- the original OMPCs	3094
similar to GDNF-induced OMPCs , -LRB- D -RRB-	3094
similar to GDNF-induced OMPCs	3094
D	3126
the original OMPCs	3129
GFAP-free	3149
NG2	3179
fewer cells	3188
O4 -LRB- scale bar , 20µm -RRB-	3210
O4	3210
scale bar	3214
20µm	3225
Fig. 2 .	3233
Fig.	3233
2	3238
-LRB- A -RRB- Photomicrographs of a longitudinal section of spinal cord	3241
-LRB- A -RRB- Photomicrographs	3241
A	3242
a longitudinal section of spinal cord	3265
a longitudinal section	3265
spinal cord	3291
8 weeks after treatment	3303
8 weeks	3303
treatment	3317
The white arrow	3328
the T8 transection site	3350
-LRB- B and C -RRB-	3375
B	3376
C	3382
Higher magnification images of regions outlined in -LRB- A -RRB-	3385
Higher magnification images	3385
regions outlined in -LRB- A -RRB-	3416
regions	3416
A	3437
Some BrdU-labeled OMPCs	3441
Some	3441
OMPCs	3459
NG2 + cells	3485
the rostral	3499
B , white arrow	3512
B	3512
white arrow	3515
caudal stumps	3532
C , white arrow	3547
C	3547
white arrow	3550
the spinal cord transected site	3566
Scale bar	3599
100µm	3612
-LRB- D -RRB- Less GFAP + cells	3619
-LRB- D -RRB- Less	3619
-LRB- D -RRB-	3619
GFAP + cells	3628
BrdU + cells near the spinal cord lesion regions	3656
BrdU + cells	3656
the spinal cord lesion regions	3673
OMPC transplantation	3710
-LRB- E and F -RRB-	3732
E	3733
F	3739
Higher magnification images from the regions in -LRB- D -RRB-	3742
Higher magnification images	3742
the regions in -LRB- D -RRB-	3775
the regions	3775
D	3791
BrdU + cells	3795
BrdU	3795
cells	3801
the spinal cord transection site	3824
these cells	3862
astrocytes	3901
GFAP -LRB- green -RRB-	3924
GFAP	3924
Sham control -LRB- injury alone without treatment group -RRB-	3938
Sham control	3938
injury alone without treatment group	3952
injury alone	3952
treatment group	3973
G	4004
no BrdU + cells	4012
no BrdU	4012
cells	4021
the injected region of spinal cord	4045
the injected region	4045
spinal cord	4068
There	4081
a strong expression of GFAP in the lesion	4091
a strong expression	4091
GFAP in the lesion	4114
GFAP	4114
the lesion	4122
the GFAP + areas	4138
the GFAP	4138
areas	4148
the exogenous grafting cells	4163
Fig. 3 .	4194
Fig.	4194
3	4199
The rat motor function behavior	4202
the treadmill	4237
ChABC treatment and OMPC transplantation	4257
ChABC treatment	4257
OMPC transplantation	4277
-LRB- A -RRB- For the intact animal , the treadmill walking	4299
-LRB- A -RRB-	4299
the intact animal , the treadmill walking	4307
the intact animal	4307
the treadmill walking	4326
the treadmill	4326
a recorded graph	4358
a standard reference gait	4381
the servo-controlled BWS	4414
the treadmill walking gaits of left and right hind limbs	4440
the treadmill	4440
gaits of left and right hind limbs	4462
gaits	4462
left and right hind limbs	4471
-LRB- B -RRB-	4523
The walking measure data from the left and right hind limbs of rats	4527
The walking measure data	4527
the left and right hind limbs of rats	4557
the left and right hind limbs	4557
rats	4590
spinal cord injury	4600
treatment	4637
-LRB- C -RRB- The kinematic trajectory of combined treatment	4660
The kinematic trajectory	4664
combined treatment	4692
ChABC delivery and OMPC graft	4712
ChABC delivery	4712
OMPC graft	4731
the normal trajectory	4753
-LRB- D -RRB-	4776
The photo of sham control -LRB- non-repair -RRB- and -LRB- E -RRB- post-repair	4780
The photo of sham control -LRB- non-repair -RRB-	4780
The photo	4780
sham control	4793
non-repair	4807
E	4824
post-repair	4827
spinal cord injury	4848
injured axons	4868
The cellular and molecular mechanisms of regenerative failure after SCI	4899
The cellular and molecular mechanisms	4899
regenerative failure after SCI	4940
regenerative failure	4940
SCI	4967
there	4995
no significant effect on the motor function improvement -LSB- 10 -RSB-	5005
no significant effect	5005
the motor function improvement -LSB- 10 -RSB-	5030
the motor function improvement	5030
10 -RSB-	5062
SCI	5073
a cascade of cellular and molecular responses	5078
a cascade	5078
cellular and molecular responses	5091
the formation of a dense astroglial scar at the lesion site	5136
the formation	5136
a dense astroglial scar at the lesion site	5153
a dense astroglial scar	5153
the lesion site	5180
Chondroitin sulfate proteoglycan -LRB- CSPG -RRB-	5197
Chondroitin sulfate proteoglycan	5197
CSPG	5231
a major component of glial scars in injured spinal cords -LSB- 10,12,13 -RSB-	5240
a major component	5240
glial scars in injured spinal cords -LSB- 10,12,13 -RSB-	5261
glial scars	5261
injured spinal cords -LSB- 10,12,13 -RSB-	5276
injured spinal cords	5276
10,12,13 -RSB-	5298
Chondroitinase ABC -LRB- ChABC -RRB-	5309
Chondroitinase ABC	5309
ChABC	5329
a bacteria enzyme	5339
chondroitin sulfate proteoglycan glycosaminoglycan -LRB- CSPG-GAG -RRB-	5377
chondroitin sulfate proteoglycan glycosaminoglycan	5377
CSPG-GAG	5429
axonal sprouting and functional recovery in various animal models -LSB- 9 -RSB-	5461
axonal sprouting and functional recovery	5461
various animal models	5505
we	5546
the digested products	5565
ChABC treatment and a small number of axonal fibers	5603
ChABC treatment	5603
a small number of axonal fibers	5623
a small number	5623
axonal fibers	5641
HRP-tracer	5672
the spinal cord lesion area -LSB- 8 -RSB-	5690
the spinal cord lesion area	5690
8 -RSB-	5719
Our previous study	5723
sustained delivery	5756
ChABC	5778
intrathecal catheter -LRB- 1 U/ml , injection volume 6µl for one animal -RRB-	5788
intrathecal catheter	5788
1 U/ml , injection volume 6µl for one animal	5810
1 U/ml , injection volume 6µl	5810
1 U/ml , injection volume	5810
1 U/ml	5810
injection volume	5818
one animal	5843
the fractional functional behavior in SCI rats	5869
the fractional functional behavior	5869
SCI rats	5907
the BBB scale	5929
we	5953
the limited functional recovery	5974
the absence	6022
a myelin sheath , which surrounded the regrown axons within the lesion site	6037
a myelin sheath	6037
the regrown axons	6071
the lesion site	6096
Cellular transplantation	6113
a potential therapeutic strategy	6163
neural regeneration	6207
SCI	6230
Previous reports	6235
transplantation of olfactory ensheathing cells -LRB- OECs -RRB- or Schwann cells	6272
transplantation	6272
olfactory ensheathing cells -LRB- OECs -RRB- or Schwann cells	6291
OECs	6320
the sprouting of axons across the lesion site in spinal cord	6355
the sprouting	6355
axons across the lesion site in spinal cord	6372
axons	6372
the lesion site in spinal cord	6385
the lesion site	6385
spinal cord	6404
remyelination	6427
the re-grown axons -LSB- 3,18 -RSB-	6448
the re-grown axons	6448
3,18 -RSB-	6468
the combination of cell transplantation with ChABC	6481
the combination	6481
cell transplantation with ChABC	6500
cell transplantation	6500
ChABC	6526
a potent therapeutic strategy for SCI	6539
a potent therapeutic strategy	6539
SCI	6573
the combined therapeutic effects	6590
stem cell transplantation and ChABC treatment in SCI rats	6626
stem cell transplantation and ChABC treatment	6626
SCI rats	6675
olfactory mucosa progenitor cells -LRB- OMPCs -RRB-	6685
olfactory mucosa progenitor cells	6685
OMPCs	6720
the adult rat olfactory mucosa of intact rats -LRB- 250 -- 300 g -RRB-	6746
the adult rat olfactory mucosa	6746
intact rats -LRB- 250 -- 300 g -RRB-	6780
intact rats	6780
250 -- 300 g	6793
250	6793
300 g	6797
neurobasal medium	6820
B27 supplement	6849
bFGF 20 ng/ml	6865
heparin 5 g/ml	6880
EGF 20 ng/ml -LRB- Invitrogen -RRB-	6896
EGF	6896
20 ng/ml -LRB- Invitrogen -RRB-	6900
Invitrogen	6910
glial cell line-derived neurotrophin factor -LRB- GDNF -RRB- 10 ng/ml	6923
glial cell line-derived neurotrophin factor	6923
GDNF	6968
10 ng/ml	6974
antibiotics for 5 -- 7 days to generate neurosphere suspension	6987
antibiotics for 5	6987
antibiotics	6987
5	7003
7 days to generate neurosphere suspension	7005
7 days	7005
neurosphere suspension	7024
The neurospheres with a diameter of 150 -- 200µm	7048
The neurospheres	7048
a diameter of 150 -- 200µm	7070
a diameter of 150	7070
a diameter	7070
150	7084
200µm	7088
them	7124
0.025 % trypsin -- EDTA in Ca2 + -	7134
0.025 % trypsin	7134
EDTA in Ca2	7149
EDTA	7149
Ca2	7157
+	7160
Mg2	7167
+	7170
free solution -LRB- GIBCO , Grand Island , NY -RRB-	7172
free solution	7172
GIBCO	7187
Grand Island	7194
NY	7208
5 min	7216
them	7239
solution	7266
OMPCs	7276
37 ◦ C	7300
5 % CO2 in air , for 2 weeks subcultured	7312
5 % CO2	7312
air	7322
2 weeks subcultured	7331
2 weeks	7331
the incubation in neurobasal medium	7362
the incubation	7362
neurobasal medium	7380
OMPCs	7399
cellular characterization	7426
immunocytochemistry assay	7455
The neurospheres with a diameter of 150 -- 200µm	7482
The neurospheres	7482
a diameter of 150 -- 200µm	7504
a diameter of 150	7504
a diameter	7504
150	7518
200µm	7522
the pre-coated poly-l-lysine -LRB- 10µg/ml -RRB- dish	7543
10µg/ml	7573
our defined differentiation medium	7605
B27 supplement solution and laminin -LRB- 5µg/ml -RRB-	7641
B27 supplement solution and laminin	7641
B27 supplement solution	7641
laminin	7669
5µg/ml	7678
the DMEM/F12 culture medium -LRB- Invitrogen -RRB-	7700
the DMEM/F12 culture medium	7700
Invitrogen	7729
every 2 days	7759
7 days of incubation	7777
7 days	7777
incubation	7787
we	7799
the cells	7808
acetone/absolute alcohol -LRB- 1:1 -RRB-	7823
acetone/absolute alcohol	7823
1:1	7849
4 ◦ C for 20 min	7857
4 ◦ C	7857
20 min	7866
the solution to wash the cells twice -LRB- 5 min each time -RRB-	7886
the solution to wash the cells twice	7886
the cells	7907
5 min each time	7924
5 min	7924
each time	7930
The cells	7942
0.2 % Triton-X 100 -LRB- Sigma , St. Louis , MO -RRB-	7968
0.2 % Triton-X	7968
100 -LRB- Sigma , St. Louis , MO -RRB-	7982
100	7982
Sigma	7987
St. Louis	7994
MO	8004
PBS	8010
room temperature for 30 min	8017
room temperature	8017
30 min	8038
2 % BSA -LRB- bovine serum albumin -RRB- in PBS	8060
2 % BSA -LRB- bovine serum albumin -RRB-	8060
2 % BSA	8060
bovine serum albumin	8068
PBS	8093
a blocking solution at room temperature for 1 h. Primary antibodies	8109
a blocking solution	8109
room temperature for 1 h. Primary antibodies	8132
room temperature	8132
1 h. Primary antibodies	8153
1 % BSA	8195
PBS	8205
O4 -LRB- 1:500 -RRB-	8220
O4	8220
1:500	8224
NG2 -LRB- 1:500 -RRB-	8235
NG2	8235
1:500	8240
a marker for oligodendrocyte progenitor cells	8248
a marker	8248
oligodendrocyte progenitor cells	8261
GFAP -LRB- 1:500 -RRB- a marker of astrocytes	8295
GFAP -LRB- 1:500 -RRB-	8295
GFAP	8295
1:500	8301
a marker of astrocytes	8308
a marker	8308
astrocytes	8320
peripherin	8336
1:500	8348
a cellular marker of developing neurons	8356
a cellular marker	8356
developing neurons	8377
all from Chemicon	8397
all	8397
Chemicon	8406
Tamecula , CA	8416
Tamecula	8416
CA	8426
We	8431
five regions	8443
each	8459
the immunopositive cells	8481
them	8517
all of the cells	8527
all	8527
the cells	8534
each region	8549
Fig. 1	8574
OMPCs	8587
10 ng/ml	8610
GDNF-containing medium	8619
the cell	8652
a branching neurite , oligodendrocyte progenitor cell-like morphology	8665
a branching neurite	8665
oligodendrocyte progenitor cell-like morphology	8686
cells	8739
extended neurites	8755
A large number of OMPCs	8774
A large number	8774
OMPCs	8792
NG2 -LRB- a marker of oligodendrocyte progenitor cells -RRB-	8808
NG2	8808
a marker of oligodendrocyte progenitor cells	8813
a marker	8813
oligodendrocyte progenitor cells	8825
O4 -LRB- for mature oligodendrocytes -RRB-	8863
O4	8863
mature oligodendrocytes	8871
Representative photomicrographs	8897
OMPCs	8945
oligodendrocyte progenitor cells expressing NG2 -LRB- red -RRB-	8961
oligodendrocyte progenitor cells	8961
NG2 -LRB- red -RRB-	9005
NG2	9005
red	9010
O4-immunopositive cells -LRB- green -RRB-	9036
O4-immunopositive cells	9036
the role of grafted OMPCs in regeneration of SCI rats	9087
the role	9087
grafted OMPCs in regeneration of SCI rats	9099
grafted OMPCs	9099
regeneration of SCI rats	9116
regeneration	9116
SCI rats	9132
we	9142
BrdU -LRB- 5mM , incubated for 24 h -RRB-	9150
BrdU	9150
5mM , incubated for 24 h	9156
5mM	9156
24 h	9175
the OMPCs	9190
transplantation	9207
The BrdU-labeled OMPCs	9224
the parenchyma of injured site of spinal cord	9270
the parenchyma	9270
injured site of spinal cord	9288
injured site	9288
spinal cord	9304
a Hamilton syringe	9322
ChABC delivery	9347
8 weeks	9369
the rats	9378
100 ml PBS and 300 ml cold 4 % paraformaldehyde solution ; and pH 7.4	9406
100 ml PBS	9406
300 ml cold 4 % paraformaldehyde solution	9421
300 ml	9421
cold 4 % paraformaldehyde solution	9428
pH 7.4	9467
Spinal cord tissues from both lesion sites and noninjured spinal cords	9475
Spinal cord tissues	9475
both lesion sites and noninjured spinal cords	9500
both lesion sites	9500
noninjured spinal cords	9522
15 mm from the lesion area in both the proximal and caudal stumps	9547
15 mm	9547
the lesion area in both the proximal and caudal stumps	9557
the lesion area	9557
both the proximal and caudal stumps	9576
4 % paraformaldehyde solution for an additional 12 h	9644
4 % paraformaldehyde solution	9644
an additional 12 h	9677
The cryosection -LRB- 20µm -RRB-	9697
The cryosection	9697
20µm	9714
the immunochemistry procedure	9744
incubation with 5 % bovine serum albumin in PBS for 30 min	9785
incubation	9785
5 % bovine serum albumin	9801
PBS for 30 min	9828
PBS	9828
30 min	9836
monoclonal antibody	9844
GAP-43 -LRB- 1:1000 ; Sigma , St. Louis , MO -RRB-	9867
GAP-43	9867
1:1000 ; Sigma	9875
1:1000	9875
Sigma	9883
St. Louis , MO	9890
St. Louis	9890
MO	9901
BrdU -LRB- 1:5000 ; Seikagaku Corporation -RRB-	9906
BrdU	9906
1:5000 ; Seikagaku Corporation	9912
1:5000	9912
Seikagaku Corporation	9920
GFAP -LRB- 1:1000 ; Sigma -RRB-	9944
GFAP	9944
1:1000 ; Sigma	9950
1:1000	9950
Sigma	9958
NG2 -LRB- 1:1000 ; DAKO -RRB-	9969
NG2	9969
1:1000 ; DAKO	9974
1:1000	9974
DAKO	9982
primary antibodies	10001
Appropriate secondary antibody plus ABC procedure	10021
Appropriate secondary antibody	10021
ABC procedure	10057
peroxidase staining for GAP-43	10085
peroxidase staining	10085
GAP-43	10109
Anti-mouse	10117
anti-rabbit and antigoat secondary antibodies	10129
Alexa Flour-488 and 568	10189
Alexa Flour-488	10189
568	10209
other signals such as GFAP , NG2 , and BrdU	10233
other signals	10233
GFAP , NG2 , and BrdU	10255
GFAP	10255
NG2	10261
BrdU	10270
the results shown in Fig. 2	10283
the results	10283
Fig. 2	10304
the BrdU + cells	10312
the BrdU	10312
cells	10322
NG2	10351
the lesion site -LRB- Fig. 2A -RRB-	10359
the lesion site	10359
Fig. 2A	10376
8 weeks of transplantation	10391
8 weeks	10391
transplantation	10402
The grafted OMPCs	10419
the fate specific cell lineages	10476
These OMPCs	10509
the types of progenitor	10537
the types	10537
progenitor	10550
NG2 + cells , Fig. 2B and C	10562
NG2 + cells	10562
Fig. 2B and C	10574
the spinal cord lesion region	10596
Fewer GFAP + cells	10627
Fewer GFAP	10627
cells	10639
BrdU + cells near spinal cord lesion regions	10661
BrdU + cells	10661
spinal cord lesion regions	10678
OMPC transplantation -LRB- Fig. 2D -- F -RRB-	10711
OMPC transplantation	10711
Fig. 2D -- F	10733
Fig. 2D	10733
F	10741
higher magnification images	10770
the regions in Fig. 2D	10803
the regions	10803
Fig. 2D	10818
it	10827
BrdU + cells -LRB- red -RRB-	10849
BrdU + cells	10849
red	10862
the spinal cord transection site	10884
these cells	10921
astrocytes	10960
GFAP -LRB- green -RRB-	10983
GFAP	10983
Our experimental results	10997
these grafted OMPCs	11038
their differentiated courses	11090
their	11090
courses	11111
OMPCs	11128
the pattern of oligodendrocyte progenitor cells	11150
the pattern	11150
oligodendrocyte progenitor cells	11165
NG2	11209
the spinal cord lesion region 8 weeks	11220
the spinal cord lesion region	11220
8 weeks	11250
transplantation	11264
we	11290
the possibility	11309
the local environment following injury	11330
the differentiation date for the grafted OMPCs	11390
the differentiation date	11390
the grafted OMPCs	11419
the previous studies	11449
cell therapy	11485
the sprouting of axons across the spinal cord lesion site	11513
the sprouting	11513
axons across the spinal cord lesion site	11530
axons	11530
the spinal cord lesion site	11543
remyelination	11582
the re-grown axons	11603
recent progress in stem cell therapy	11628
recent progress	11628
stem cell therapy	11647
the timing of stem cell transplantation	11666
the timing	11666
stem cell transplantation	11680
the survival and differentiation	11721
grafted cells	11757
functional improvement in terms of the injured spinal cord microenvironment	11775
functional improvement	11775
terms of the injured spinal cord microenvironment	11801
terms	11801
the injured spinal cord microenvironment	11810
The results	11852
theOMPCsfollowing GDNF-induction	11879
the mature cell lineages in vivo	11939
the mature cell lineages	11939
vivo	11967
We	11973
the extracellular matrices -LRB- ECMs -RRB-	11994
the extracellular matrices	11994
ECMs	12022
factors within injured tissues in spinal cord	12032
factors	12032
injured tissues in spinal cord	12047
injured tissues	12047
spinal cord	12066
the differentiation of grafted OMPCs	12094
the differentiation	12094
grafted OMPCs	12117
Substantial evidence	12132
complex ECMs and factors	12184
nervous system plasticity regulation	12225
response	12269
injuries	12281
ECM component modification	12291
axonal regeneration	12351
the endogenous neural progenitor cells	12383
the destroyed cells	12433
the spinal cord lesion region -LSB- 11 -RSB-	12460
the spinal cord lesion region	12460
11 -RSB-	12491
the detailed interactions	12502
grafted OMPC and local environment of injured spinal cords	12536
grafted OMPC	12536
local environment of injured spinal cords	12553
local environment	12553
injured spinal cords	12574
our next study	12630
our pilot study	12649
the motor function	12666
BBB	12707
Neither ChABC alone nor OMPC	12712
ChABC alone	12720
OMPC	12736
scale 4 , which indicates the weight bearing ability	12758
scale 4	12758
the weight bearing ability	12783
contrast	12814
the	12824
treatment -LRB- ChABC + OMPC -RRB-	12836
treatment	12836
ChABC + OMPC	12847
ChABC	12847
OMPC	12854
scale 4 since the third week -LRB- Fig	12868
scale 4	12868
the third week -LRB- Fig	12882
the third week	12882
Fig	12898
S1	12903
the following study	12918
the combine treatment	12953
the combined effect of OMPC transplantation	12995
the combined effect	12995
OMPC transplantation	13018
parenchyma of spinal cord	13053
parenchyma	13053
spinal cord	13067
a Hamilton syringe and long-term administration	13085
ChABC	13136
1 U/ml , total volume is 6µl	13143
1 U/ml	13143
total volume is 6µl	13151
total volume	13151
intrathecal catheter	13176
every other days	13197
2 weeks -LRB- total eight times , each time 1 U/ml , 6µl -RRB-	13218
total eight times , each time 1 U/ml , 6µl	13227
total eight times	13227
each time 1 U/ml	13246
6µl	13264
inhalation of asesthesia -LSB- 8 -RSB-	13275
inhalation	13275
asesthesia -LSB- 8 -RSB-	13289
asesthesia	13289
8 -RSB-	13301
kinematic recording and analyses of bipedal training in the animal treadmill	13305
kinematic recording and analyses	13305
bipedal training in the animal treadmill	13341
bipedal training	13341
the animal treadmill	13361
the functional improvement	13403
repaired rats	13433
the delivery of ChABC combined with OMPC transplantation	13448
the delivery	13448
ChABC	13464
OMPC transplantation	13484
sham control rats at 8-week post-injury	13510
sham control rats	13510
8-week post-injury	13531
The walking kinematic trajectories of injured and repaired rats	13551
The walking kinematic trajectories of injured	13551
The walking kinematic trajectories	13551
injured	13589
repaired rats	13601
the treadmill	13647
the servo-controlled body weight support -LRB- BWS -RRB- -LSB- 4,6,7,17 -RSB-	13667
the servo-controlled body weight support -LRB- BWS -RRB-	13667
the servo-controlled body weight support	13667
BWS	13709
4,6,7,17 -RSB-	13715
brief	13729
all experimental rats	13736
a treadmill	13773
a period of 1 week as treadmill training	13802
a period	13802
1 week as treadmill training	13814
1 week	13814
treadmill training	13824
all experimental procedures	13861
One week	13890
both the sham control -LRB- SCI alone -RRB- and treatment groups	13906
the sham control -LRB- SCI alone -RRB- and treatment groups	13911
the sham control -LRB- SCI alone -RRB-	13911
the sham control	13911
SCI	13929
treatment groups	13944
the treadmill	13976
their walking gait	14002
Locomotor training	14022
daily sessions -LRB- 5 days/week -RRB- of 20 min bipedal treadmill training	14054
daily sessions -LRB- 5 days/week -RRB-	14054
daily sessions	14054
5 days/week	14070
20 min bipedal treadmill training	14086
20 min	14086
Bipedal training	14121
a standard procedure in previous experiments	14155
a standard procedure	14155
previous experiments	14179
complete spinal cord transection	14206
treatments -LSB- 14 -RSB-	14248
treatments	14248
14 -RSB-	14260
A hollow cylinder made of heavy cloth	14265
A hollow cylinder	14265
heavy cloth	14291
the end of the BWS arm	14317
the end	14317
the BWS arm	14328
the rats	14351
their head and upper body	14374
their hind limbs	14407
their weight	14434
the moving treadmill belt	14450
This procedure	14477
a bipedal stance	14502
the rats	14532
a harness	14564
The rate of treadmill training	14575
The rate	14575
treadmill training	14587
7 cm/s	14617
a maximum of 21 cm/s for 20 min	14636
a maximum	14636
21 cm/s for 20 min	14649
21 cm/s	14649
20 min	14661
training	14675
the rats	14685
20 cm/s for 20 min	14715
20 cm/s	14715
20 min	14727
the third week of training	14737
the third week	14737
training	14755
A sweet cereal reward	14765
each rat	14800
the bipedal training sessions	14815
A series	14846
parameters	14858
the gait timing	14880
the characteristics of limb trajectory	14897
the characteristics	14897
limb trajectory	14920
the spatial and temporal features of the kinematic patterns	14941
the spatial and temporal features	14941
the kinematic patterns	14978
each animal	15019
A gait cycle	15032
the time interval between two successive paw contacts	15060
the time interval	15060
two successive paw contacts	15086
one limb	15117
Thirty successive paw contacts and consistent hind limb gait cycles	15127
Thirty successive paw contacts	15127
consistent hind limb gait cycles	15162
each animal	15223
Footfall patterns	15236
the coupling between the hind limbs -LSB- 5,19,22 -RSB-	15275
the coupling	15275
the hind limbs -LSB- 5,19,22 -RSB-	15296
the hind limbs	15296
5,19,22 -RSB-	15312
the results in Fig. 3	15329
the results	15329
Fig. 3	15344
the treadmill walking patterns of repaired rats -LRB- Fig. 3C -RRB-	15352
the treadmill	15352
patterns of repaired rats -LRB- Fig. 3C -RRB-	15374
patterns	15374
repaired rats -LRB- Fig. 3C -RRB-	15386
repaired rats	15386
Fig. 3C	15401
that of the normal ones -LRB- Fig. 3A -RRB-	15426
that	15426
the normal ones -LRB- Fig. 3A -RRB-	15434
the normal ones	15434
Fig. 3A	15451
the magnitude	15470
the effect	15487
the right hind limbs	15511
repaired rats -LRB- Fig. 3E , marked with a red circle -RRB-	15535
repaired rats	15535
Fig. 3E , marked with a red circle	15550
Fig. 3E	15550
marked with a red circle	15559
marked	15559
a red circle	15571
summary	15604
the movement pattern	15613
combined treated -LRB- ChABC with OMPC transplantation -RRB- rats	15637
ChABC with OMPC transplantation	15655
ChABC	15655
OMPC transplantation	15666
the intact rats -LRB- Fig. 3A -RRB-	15704
the intact rats	15704
Fig. 3A	15721
Stepping of treated rats on the treadmill	15731
Stepping	15731
treated rats on the treadmill	15743
treated rats	15743
the treadmill	15759
short , well-coordinated steps , small variability and minimal toe dragging	15810
short , well-coordinated steps	15810
small variability	15841
minimal toe dragging	15863
minimal toe	15863
Kinematic gait analysis and paw-spread	15885
Kinematic gait analysis	15885
paw-spread	15913
small changes	15958
hind limb function	15975
this study	15998
similar treadmill training	16010
the difference between treated and untreated SCI rats	16057
the difference between treated and untreated SCI	16057
the difference	16057
treated and untreated SCI	16080
The gait patterns	16112
the treated rats following OMPC transplantation and ChABC delivery	16133
the treated rats	16133
OMPC transplantation and ChABC delivery	16160
OMPC transplantation	16160
ChABC delivery	16185
the patterns of intact rats	16213
the patterns	16213
intact rats	16229
the untreated group	16254
these grafted OMPCs	16284
mature cell phenotypes	16321
they	16345
the spinal cord lesion region	16382
the functional improvement	16416
gait analysis on the treadmill	16462
gait analysis	16462
the treadmill	16479
The hypothesis associated with immunomodulation of OMPC transplantation	16494
The hypothesis	16494
immunomodulation of OMPC transplantation	16525
immunomodulation	16525
OMPC transplantation	16545
detail in future	16590
detail	16590
future	16600
The distinct effects of ChABC	16608
The distinct effects	16608
ChABC	16632
the timing of delivery	16661
the timing	16661
delivery	16675
SCI	16691
CSPGs	16708
the lesion site	16749
Sustained delivery	16766
ChABC with the safety and the lowest dose via intrathecal catheter	16788
ChABC with the safety	16788
ChABC	16788
the safety	16799
the lowest dose via intrathecal catheter	16814
the lowest dose	16814
intrathecal catheter	16834
injured spinal cord	16882
fractional motor functions	16914
8 -RSB-	16942
the substrate modification	16960
the outcome of macrophage attack	16997
the outcome	16997
macrophage attack	17012
in vivo ChABC treatment within the lesion site	17035
in vivo ChABC treatment	17035
the lesion site	17066
CNS regeneration	17107
macrophage-induced retraction of axons -LSB- 2 -RSB-	17138
macrophage-induced retraction	17138
axons -LSB- 2 -RSB-	17171
axons	17171
2 -RSB-	17178
ChABC	17182
the local environment of lesion region	17205
the local environment	17205
lesion region	17230
spinal cord	17247
intrinsic sensory neurons growth capacity	17270
the dorsal columns -LSB- 2,15 -RSB-	17315
the dorsal columns	17315
2,15 -RSB-	17335
several factors	17351
the effect of ChABC in vivo.ChABCis	17373
the effect	17373
ChABC in vivo.ChABCis	17387
ChABC	17387
vivo.ChABCis	17396
its enzymatic activity	17440
3	17478
5 days at 37 ◦ C -LSB- 20 -RSB-	17480
5 days	17480
The infusion frequency of ChABC via intrathecal catheter or injection	17502
The infusion frequency	17502
ChABC via intrathecal catheter or injection	17528
ChABC	17528
intrathecal catheter or injection	17538
the least 2 -- 3 days -LSB- 20 -RSB-	17591
the least 2	17591
3 days -LSB- 20 -RSB-	17603
3 days	17603
20 -RSB-	17611
There	17616
clinically viable delivery methods	17654
the spatially and temporally controlled delivery of ChABC	17693
the spatially and temporally controlled delivery	17693
ChABC	17745
Cell-based therapy	17752
an attractive strategy for spinal cord injury or diseases	17780
an attractive strategy	17780
spinal cord injury or diseases	17807
spinal cord injury	17807
diseases	17829
the loss of both neurons and glial cells	17850
the loss	17850
both neurons and glial cells	17862
both neurons	17862
glial cells	17879
SCI	17897
cell-based strategies for reconstituting the injured spinal cord	17908
cell-based strategies	17908
the injured spinal cord	17949
damaged cell types	18007
the rapid pace of advance in our understanding , cell-based therapy	18031
the rapid pace	18031
advance in our understanding , cell-based therapy	18049
advance	18049
our understanding , cell-based therapy	18060
our understanding	18060
cell-based therapy	18079
the only one role	18105
cellular replacement in SCI	18127
cellular replacement	18127
SCI	18151
Cell transplants	18156
motor function	18181
a combination	18209
the activation of endogenous stem/progenitor cells	18311
the activation	18311
endogenous stem/progenitor cells	18329
The grafted cells	18363
immunomodulatory properties -LSB- 16,21 -RSB-	18413
immunomodulatory properties	18413
16,21 -RSB-	18442
it	18456
the grafted cells	18490
axonal elongation	18524
functional recovery	18554
our studies	18578
the reason	18591
the OMPCs	18607
their NG2 immunoreactivity	18626
oligodendrocyte progenitor cells -LRB- OPCs -RRB- at long survivals	18656
oligodendrocyte progenitor cells -LRB- OPCs -RRB-	18656
oligodendrocyte progenitor cells	18656
OPCs	18690
long survivals	18699
8 weeks of transplantation	18726
8 weeks	18726
transplantation	18737
Previous	18775
progenitor cells	18809
growth factors	18840
factors , and neurotrophic factors	18871
factors	18871
neurotrophic factors	18884
neurogenesis and synaptic plasticity	18917
their development	18961
It	18980
quantitative techniques	19009
motor function	19043
treatment	19064
The locomotor functions	19075
swing velocity , step height , hindlimb coordination , and ability	19107
swing velocity	19107
step height	19123
hindlimb coordination	19136
ability	19163
body weight	19182
Basso , Beattie , and Bresnahan -LRB- BBB -RRB- scale analysis	19222
Basso	19222
Beattie	19229
Bresnahan -LRB- BBB -RRB- scale analysis	19242
Bresnahan	19242
BBB	19253
scale analysis	19258
Robotic gait analysis of bipedal treadmill	19274
Robotic gait analysis	19274
bipedal treadmill	19299
an objective	19328
rapid behavioral assessment of locomotor function -LSB- 1,14 -RSB-	19345
rapid behavioral assessment	19345
locomotor function -LSB- 1,14 -RSB-	19376
locomotor function	19376
1,14 -RSB-	19396
